Traders cheered Aurobindo's in-line performance by sending the stock nearly 4 percent higher. But they punished Sun Pharma for missing Street estimates across the board by sending the stock down over 6 percent. CNBC-TV18's Ekta Batra and Archana Shukla crunch the numbers.
first published: May 31, 2016 09:54 pm
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty extend gains to third day and reclaim record highs? | Opening Bell
Decoding Small-Caps - Opportunities, Risks, and the Right Way to Invest
Live: Broad-based buying lifts D-Street for 2nd day, Nifty above 26,100 | Closing Bell
In your 20s? Quick hacks to turn your money mess into money moves
